Examining The Value And Future Of Drug Repurposing In Life Sciences
Source: Verista
In the life sciences industry, many drugs on the market today have been approved for indications for which they were not originally developed. Sometimes, discovering a new use for a drug happens by chance during a clinical trial or post-market, as more information is learned about the drug’s effects that weren’t originally predicted.
Though, in the last decade or so, the industry has identified a more systematic and rational approach to incorporating a repurposing strategy into drug discovery and development. Learn about approaches to drug repurposing, how COVID-19 is impacting drug repurposing, and more.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Verista
This website uses cookies to ensure you get the best experience on our website. Learn more